[1] KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell , 1987, 51(3): 503-512. [2] SL, Thomas KR, Capecchi MR. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature , 1988, 336(6197): 348-352. [3] 肖安, 黄鹏, 王唯晔, 朱作言, 张博. 类转录激活因子效应物核酸酶(TALEN)介导的基因组定点修饰技术. 遗传, 2013, 35(4): 395-409. [4] 胡莹莹, 王唯晔, 杨志苖, 王展翔, 黄鹏, 佟向军, 张博, 林硕. 人工锌指核酸酶介导的基因组定点修饰技术. 遗传, 2011, 33(7): 665-683. [5] J, Yang HQ, Fan NN, Zhao BT, Ouyang Z, Liu ZM, Zhao Y, Li XP, Song J, Yang Y, Zou QJ, Yan QM, Zeng YZ, Lai LX. Highly efficient generation of GGTA1 biallelic knockout inbred mini-pigs with TALENs. PLoS ONE , 2013, 8(12): e84250. [6] DF, Tan W, Lillico SG, Stverakova D, Proudfoot C, Christian M, Voytas DF, Long CR, Whitelaw CBA, Fahrenkrug SC. Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci USA , 2012, 109(43): 17382- 17387. [7] J, Bonas U. Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu Rev Phytopathol , 2010, 48(1): 419-436. [8] Y, Guo X, Liu Y, Cao Y, Deng Y, Chen X, Cheng CHK, Dawid IB, Chen Y, Zhao H. Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs). Proc Natl Acad Sci USA , 2012, 109(43): 17484-17489. [9] W, Carlson DF, Lancto CA, Garbe JR, Webster DA, Hackett PB, Fahrenkrug SC. Efficient nonmeiotic allele introgression in livestock using custom endonucleases. Proc Natl Acad Sci USA , 2013, 110(41): 16526-16531. [10] YL, Li J, Liu Y, Lin L, Du YT, Li ST, Yang HM, Vajta G, Callesen H, Bolund L, Sørensen CB. High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: developing a pig model for breast cancer. Transgenic Res , 2011, 20(5): 975-988. [11] A, Hwa V, Metherell LA, Netchine I, Camacho-Hübner C, Clark AJL, Rosenfeld RG, Savage MO. Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity. Endocr Rev , 2011, 32(4): 472-497. [12] MO, Attie KM, David A, Metherell LA, Clark AJ, Camacho-Hubner C. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders. Nat Clin Pract Endocrinol Metab , 2006, 2(7): 395-407. [13] JA, Wang X, Kopchick JJ. Porcine growth hormone receptor cDNA sequence. Nucleic Acids Res , 1990, 18(21): 6451-6451. [14] Z. Growth hormone insensitivity (Laron syndrome). Rev Endocr Metab Disord , 2002, 3(4): 347-355. [15] A, Buckway CK, Rosenfeld RG. Genetic defects of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab , 2000, 11(2): 39-49. [16] A, Nousia-Arvanitakis S, Tsinopoulos I, Bechlivanides C, Shevah O, Laron Z. Laron syndrome. Laron syndrome. First report from Greece. Hormones ( Athens ), 2003, 2(2): 120-124. [17] VM, Wang Y, Campbell JM, Poshusta TL, Starker CG, Krug RG, 2nd, Tan WF, Penheiter SG, Ma AC, Leung AYH, Fahrenkrug SC, Carlson DF, Voytas DF, Clark KJ, Essner JJ, Ekker SC. In vivo genome editing using a high- efficiency TALEN system. Nature , 2012, 491(7422): 114-118. [18] Y, Vo TD, Mendel MC, Greenberg SG, Wang JB, Xia DF, Miller JC, Urnov FD, Gregory PD, Holmes MC. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods , 2010, 8(1): 74-79. [19] T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res , 2011, 39(12): e82. [20] 黄鹏, 张博. TALEN 构建与斑马鱼基因组定点突变的实验方法与流程. 遗传, 2013, 35(4): 533-544. [21] 杨珍珍, 窦红伟, 李伟杭, 律波, Lars B, 杜玉涛, 谭萍萍, 马润林. 利用改进的手工克隆技术生产转GFP基因猪克隆胚胎. 遗传, 2011, 33(5): 527-532. [22] H, Li Y, Wei Q, Liu CX, Bolund L, Vajta G, Dou HW, Yang WX, Xu Y, Luan J, Wang J, Yang HM, Staunstrup NH, Du YT. Development of transgenic minipigs with expression of antimorphic human cryptochrome 1. PLoS ONE , 2013, 8(10): e76098. [23] P, Zhang Y, Dou H, Yin J, Chen Y, Pang X, Vajta G, Bolund L, Du Y, Ma RZ. Handmade cloned transgenic piglets expressing the nematode fat-1 gene. Cell Reprogram , 2012, 14(3): 258-266. [24] NN, Chen JN, Shang ZC, Dou HW, Ji GZ, Zou QJ, Wu L, He LX, Wang F, Liu K, Liu N, Han JY, Zhou Q, Pan DK, Yang DS, Zhao BT, Ouyang Z, Liu ZM, Zhao Y, Lin L, Zhong CM, Wang QL, Wang SQ, Xu Y, Luan J, Liang Y, Yang ZZ, Li J, Lu CX, Vajta G, Li ZY, Ouyang HS, Wang HY, Wang Y, Yang Y, Liu ZH,Wei H, Luan ZD, Esteban MA, Deng HK, Yang HM, Pei DQ, Li N, Pei G, Liu L, Du YT, Xiao L, Lai LX. Piglets cloned from induced pluripotent stem cells. Cell Res , 2013, 23(1): 162-166. [25] JC, Tan SY, Qiao GJ, Barlow KA, Wang JB, Xia DF, Meng XD, Paschon DE, Leung E, Hinkley SJ, Dulay GP, Hua KL, Ankoudinova I, Cost GJ, Urnov FD, Zhang HS, Holmes MC, Zhang L, Gregory PD, Rebar EJ. A TALE nuclease architecture for efficient genome editing. Nat Biotechnol , 2011, 29(2): 143-148. [26] D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC, Zeitler B, Cherone JM, Meng XD, Hinkley SJ, Rebar EJ, Gregory PD, Urnov FD, Jaenisch R. Genetic engineering of human ES and iPS cells using TALE nucleases. Nat Biotechnol , 2011, 29(8): 731-734. [27] D, Tsai SQ, Khayter C, Foden JA, Sander JD, Joung JK. FLASH assembly of TALENs for high-throug-hput genome editing. Nat Biotechnol , 2012, 30(5): 460-465. [28] L, Reyon D, Hwang WY, Tsai SQ, Patel S, Khayter C, Joung JK, Sander JD, Peterson RT, Yeh JRJ. Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs. Nucleic Acids Res , 2012, 40(16): 8001-8010. [29] FE, Reyon D, Sander JD, Martinez SA, Blackburn JS, Khayter C, Ramirez CL, Joung JK, Langenau DM. Improved somatic mutagenesis in zebrafish using transcrip-tion activator-like effector nucleases (TALENs). PLoS ONE , 2012, 7(5): e37877. [30] LX, Kang JX, Li RF, Wang JD, Witt WT, Yong HY, Hao YH, Wax DM, Murphy CN, Rieke A, Samuel M, Linville ML, Korte SW, Evans RW, Starzl TE, Prather RS, Dai YF. Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol , 2006, 24(4): 435-436. [31] DK, Zhang L, Zhou YR, Feng C, Long C, Liu X, Wan R, Zhang J, Lin AX, Dong EQ, Wang SC, Xu HG, Chen HX. Efficient production of omega-3 fatty acid desaturase (sFat-1)-transgenic pigs by somatic cell nuclear transfer. Sci China Life Sci , 2010, 53(4): 517-523. [32] CS, Hao YH, Rokhlina T, Samuel M, Stoltz DA, Li YH, Petroff E, Vermeer DW, Kabel AC, Yan ZY, Spate L, Wax D, Murphy CN, Rieke A, Whitworth K, Linville ML, Korte SW, Engelhardt JF, Welsh MJ, Prather RS. Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest , 2008, 118(4): 1571-1577. [33] CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ, Rogan MP, Pezzulo AA, Karp PH, Itani OA, Kabel AC, Wohlford-Lenane CL, Davis GJ, Hanfland RA, Smith TL, Samuel M, Wax D, Murphy CN, Rieke A, Whitworth K, Uc A, Starner TD, Brogden KA, Shilyansky J, McCray PB, Jr., Zabner J, Prather RS, Welsh MJ. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science , 2008, 321(5897): 1837- 1841. [34] PM, Nielsen AL, Li J, Du YT, Lin L, Schmidt M, Bøgh IB, Holm IE, Jakobsen JE, Johansen MG, Purup S, Bolund L, Vajta G, Jorgensen AL. Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer's disease-causing dominant mutation APPsw. Transgenic Res , 2009, 18(4): 545-558. [35] NH, Madsen J, Primo MN, Li J, Liu Y, Kragh PM, Li R, Schmidt M, Purup S, Dagnæs-Hansen F, Svensson L, Petersen TK, Callesen H, Bolund L, Mikkelsen JG. Development of transgenic cloned pig models of skin inflammation by DNA transposon-directed ectopic expression of human beta1 and alpha2 integrin. PLoS ONE , 2012, 7(5): e36658. [36] RH, Sørensen CB, Kragh PM, Christoffersen C, Mortensen MB, Tolbod LP, Thim T, Du YT, Li J, Liu Y, Moldt B, Schmidt M, Vajta G, Larsen T, Purup S, Bolund L, Nielsen LB, Callesen H, Falk E, Mikkelsen JG, Bentzon JF. Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci Transl Med , 2013, 5(166): 166ra1. [37] Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, Kopchick JJ. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA , 1997, 94(24): 13215-13220. [38] JJ, Laron Z. Is the Laron mouse an accurate model of Laron syndrome? Mol Genet Metab , 1999, 68(2): 232-236. [39] EO, Coschigano KT, Kopchick JJ. Growth hormone receptor/binding protein (GHR/BP) knockout mice: a 3-year update. Mol Genet Metab , 2001, 73(1): 1-10. [40] Z, Pertzelan A, Karp M, Keret R, Eshet R, Silbergeld A. Laron Syndrome-a unique model of IGF-1 deficiency. // Pediatric and adolescent endocrinology. Vol. 24. New York: Karger, 1993, 24: 3. [41] Z, Avitzur Y, Klinger B. Insulin Resistance in Laron Syndrome (Primary Insulin-like Growth Factor-I (IGF-I) Deficiency) and Effect of IGF-I Replacement Therapy. J Pediatr Endocrinol Metab , 1997, 10(Suppl.): 105-116. [42] KT, Clemmons D, Bellush LL, Kopchick JJ. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology , 2000, 141(7): 2608-2613. [44] 任 军) |